These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 9014814

  • 1. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells.
    Martínez-Lorenzo MJ, Alava MA, Anel A, Piñeiro A, Naval J.
    Immunology; 1996 Dec; 89(4):511-7. PubMed ID: 9014814
    [Abstract] [Full Text] [Related]

  • 2. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells.
    Martínez-Lorenzo MJ, Alava MA, Gamen S, Kim KJ, Chuntharapai A, Piñeiro A, Naval J, Anel A.
    Eur J Immunol; 1998 Sep; 28(9):2714-25. PubMed ID: 9754559
    [Abstract] [Full Text] [Related]

  • 3. CD59 cross-linking induces secretion of APO2 ligand in overactivated human T cells.
    Monleón I, Martínez-Lorenzo MJ, Anel A, Lasierra P, Larrad L, Piñeiro A, Naval J, Alava MA.
    Eur J Immunol; 2000 Apr; 30(4):1078-87. PubMed ID: 10760796
    [Abstract] [Full Text] [Related]

  • 4. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.
    Ni X, Zhang C, Talpur R, Duvic M.
    J Invest Dermatol; 2005 Apr; 124(4):741-50. PubMed ID: 15816832
    [Abstract] [Full Text] [Related]

  • 5. Expression of membrane-bound and soluble FasL in Fas- and FADD-dependent T lymphocyte apoptosis induced by mildly oxidized LDL.
    Alcouffe J, Therville N, Ségui B, Nazzal D, Blaes N, Salvayre R, Thomsen M, Benoist H.
    FASEB J; 2004 Jan; 18(1):122-4. PubMed ID: 14630709
    [Abstract] [Full Text] [Related]

  • 6. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively.
    Tóth R, Szegezdi E, Molnár G, Lord JM, Fésüs L, Szondy Z.
    Eur J Immunol; 1999 Feb; 29(2):383-93. PubMed ID: 10064053
    [Abstract] [Full Text] [Related]

  • 7. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
    Daniel PT, Oettinger U, Mapara MY, Bommert K, Bargou R, Dörken B.
    Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
    [Abstract] [Full Text] [Related]

  • 8. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R, Seifert M, Asadullah K, Volk HD.
    J Immunol; 1999 Jun 15; 162(12):7140-7. PubMed ID: 10358159
    [Abstract] [Full Text] [Related]

  • 9. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP, Chow SC.
    FEBS Lett; 2005 Nov 21; 579(28):6465-72. PubMed ID: 16289096
    [Abstract] [Full Text] [Related]

  • 10. Butyric acid-induced T-cell apoptosis is mediated by caspase-8 and -9 activation in a Fas-independent manner.
    Kurita-Ochiai T, Ochiai K, Fukushima K.
    Clin Diagn Lab Immunol; 2001 Mar 21; 8(2):325-32. PubMed ID: 11238216
    [Abstract] [Full Text] [Related]

  • 11. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.
    Xu T, Sun BC, Li Q, Hao XS.
    World J Gastroenterol; 2005 Jul 07; 11(25):3915-9. PubMed ID: 15991293
    [Abstract] [Full Text] [Related]

  • 12. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
    Silvestris F, Cafforio P, Tucci M, Del Prete A, Dammacco F.
    Mol Med; 2000 Jun 07; 6(6):509-26. PubMed ID: 10972087
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death.
    Ayroldi E, Zollo O, Cannarile L, D' Adamio F, Grohmann U, Delfino DV, Riccardi C.
    Blood; 1998 Dec 01; 92(11):4212-9. PubMed ID: 9834226
    [Abstract] [Full Text] [Related]

  • 14. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
    Zhang J, Gao JX, Salojin K, Shao Q, Grattan M, Meagher C, Laird DW, Delovitch TL.
    J Exp Med; 2000 Mar 20; 191(6):1017-30. PubMed ID: 10727463
    [Abstract] [Full Text] [Related]

  • 15. Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells.
    Oyaizu N, Kayagaki N, Yagita H, Pahwa S, Ikawa Y.
    Biochem Biophys Res Commun; 1997 Sep 18; 238(2):670-5. PubMed ID: 9299572
    [Abstract] [Full Text] [Related]

  • 16. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL.
    Clin Cancer Res; 2005 Feb 01; 11(3):1010-20. PubMed ID: 15709166
    [Abstract] [Full Text] [Related]

  • 17. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.
    Martínez-Lorenzo MJ, Anel A, Gamen S, Monle n I, Lasierra P, Larrad L, Piñeiro A, Alava MA, Naval J.
    J Immunol; 1999 Aug 01; 163(3):1274-81. PubMed ID: 10415024
    [Abstract] [Full Text] [Related]

  • 18. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
    Oberg HH, Lengl-Janssen B, Kabelitz D, Janssen O.
    Cell Immunol; 1997 Oct 10; 181(1):93-100. PubMed ID: 9344501
    [Abstract] [Full Text] [Related]

  • 19. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
    O'Connell J, O'Sullivan GC, Collins JK, Shanahan F.
    J Exp Med; 1996 Sep 01; 184(3):1075-82. PubMed ID: 9064324
    [Abstract] [Full Text] [Related]

  • 20. Monochloramine enhances Fas (APO-1/CD95)-induced apoptosis in Jurkat T cells.
    Ogino T, Ma Y, Than TA, Omori M, Okada S.
    J Leukoc Biol; 2000 Jan 01; 67(1):46-52. PubMed ID: 10647997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.